Suono Bio is developing therapeutic products for inflammatory-mediated diseases leveraging their ultra-rapid and formulation independent delivery technology. Suono Bio's platform enables rapid, localized delivery of small molecules, biologics, and nucleic acids and gene therapies without the need for encapsulation of the therapeutic.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/05/18 | undisclosed | Strategic |
FUJIFILM | undisclosed |
